Response to Omalizumab in a Patient with Pompe Disease

Authors

David Kronn, New York Medical CollegeFollow
Valerie Marrero-Stein, New York Medical CollegeFollow
Subhadra Siegel, New York Medical CollegeFollow

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

2-2018

Journal Title

Molecular Genetics and Metabolism

Department

Pediatrics

Recommended Citation

Kronn, D., Marrero-Stein, V., & Siegel, S. (2018). Response to Omalizumab in a Patient with Pompe Disease. Molecular Genetics and Metabolism, 123 (2), S81. https://doi.org/10.1016/j.ymgme.2017.12.207